向SLC15A2/PEPT2的Cefadroxil可以防止胆固醇毒性
Raul Fernandez-Prado1, Lara Valiño1, Aranzazu Pintor-Chocano2
1Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain; RICORS2040, Madrid, Spain.
Laboratory investigation; a journal of technical methods and pathology
|November 10, 2024
概括
确定脏疾病的新治疗点至关重要. 这项研究强调SLC15A2作为潜在的标,表明用cefadroxil阻止其功能可以防止毒药物对脏造成的损伤.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性损伤 (AKI) 和慢性病 (CKD) 相互关联,AKI加速CKD,CKD增加AKI风险.
- 全基因组关联研究 (GWAS) 对于发现脏疾病中的治疗点非常有价值.
- 在AKI-CKD频谱中确定共享的机制对于开发有效的治疗方法至关重要.
研究的目的:
- 通过整合人类GWAS和小鼠转录组学数据来确定AKI和CKD的可操作的治疗标.
- 调查SLC15A2的作用,一个潜在的目标,在病的发病过程中及其对治疗干预的反应.
- 探索针对SLC15A2的潜力,以减轻毒性.
主要方法:
- 结合了AKI/CKD与小鼠AKI转录组的人类GWAS数据,以确定潜在的治疗点.
- 优先考虑SLC15A2进行进一步研究,因为它在运输毒药物和现有的小分子抑制剂中的作用.
- 使用人类和小鼠近端管状细胞进行了体外研究,并对小鼠进行了体内研究,以评估胆固醇素和甲的作用.
主要成果:
- 确定了13个潜在的可操作的治疗标,包括SLC15A2,用于调节病严重程度.
- 发现SLC15A2在人类CKD的管间细胞中升级,特别是在近端管状细胞中.
- 证明塞法德罗西尔在体外减少了胆固醇诱导的细胞毒性和炎症,并在体内保护小鼠免受胆固醇毒性.
结论:
- 通过调节毒物质的运输,SLC15A2是病的有前途的治疗标.
- 针对SLC15A2使用现有药物,如塞法德罗西尔,可能提供一种预防AKI和CKD进展的策略.
- 在SLC15A2的GWAS协会为开发针对亚临床毒性干预措施提供了理由.
更多相关视频
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
6.9K
08:19Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
10.2K
相关概念视频
Drug Elimination by Renal Route: Tubular Secretion
2.2K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.2K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection
52.3K
Overview
52.3K
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
